Back to search

Article

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients

2020-07-09

Abstract excerpt

<h4>Objective</h4> Evidence-based characterization of the diagnostic and prognostic value of the hematological and immunological markers related to the epidemic of Coronavirus Disease 2019 (COVID-19) is critical to understand the clinical course of the infection and to assess in development and validation of biomarkers. <h4>Methods</h4> Based on systematic search in Web of Science, PubMed, Scopus, and Science Di...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf6627b4-58cc-5cc4-9562-f90b352df452
DOI
10.1101/2020.07.08.20141218
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patientsDOI 10.1101/2020.07.08.20141218
Implications of Laboratory Tests in Disease Grading and Death Risk-Stratification of COVID-19: A Retrospective Study in Wuhan, ChinaSemantic proximity
Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysisSemantic proximity
An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcomeSemantic proximity
Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.Semantic proximity
Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbiditiesSemantic proximity
Lymphocyte Count is a Universal Predictor to the Health Status and Outcomes of Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Regression AnalysisSemantic proximity
Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysisSemantic proximity
Prognosing the Risk of COVID-19 Death Through a Machine Learning-Based Routine Blood PanelSemantic proximity
Limited Performance of Biomarkers and Clinical Parameters in COVID–19: Improving Interpretation and Exploration of New Immunological MarkersSemantic proximity
The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective studySemantic proximity
A Prognostic Tool for COVID-19 Decision Support: The Intermountain Risk Score Predicts Major Adverse Health Events in Patients Positive for COVID-19Semantic proximity
Exposing Limitations of Clinical Laboratory Tests in COVID-19 and the Promise of Immunological BiomarkersSemantic proximity
Select a neighboring publication to make it the new centre.